Jennifer Petter: Opportunities for RNA-Targeted Therapeutics

Jennifer Petter is the founder and Chief Innovation Officer at Arrakis Therapeutics. Here she discusses the moments that led up to the founding of a successful biotech company built on a remarkable new approach in drug discovery: RNA-targeting small molecules. This back of the napkin conversation covers the standout moments in Jen’s career as well as some insightful perspectives into the future of drug discovery.Arrakis Therapeutics Website: https://arrakistx.com/

There are no comments yet.

Please log in to write the first comment.